Lipocine Inc (NASDAQ: LPCN) stock closed at $4.79 on 3/13/24 after a major increase of 21.0%. Moreover, trading volume in this advance was exceptionally high at 357% of normal. The stock has been weak relative […]
BUSINESS Hancock Whitney Corporation operates as the financial holding company for Hancock Whitney Bank that provides traditional and online banking services to commercial, small business, and retail customers. It accepts various deposit products, including noninterest-bearing […]
Luna Innovations Inc (NASDAQ: LUNA) stock suffered a major decline of -35.8% on 3/13/24. The shares closed at $4.02. Moreover, this decline was accompanied by exceptionally high trading volume at 1732% of normal. The stock […]
For its fourth fiscal quarter (ending January 31), Dollar Tree Inc (NASDAQ: DLTR) has reported a -483% decline in E.P.S. from $2.05 a year ago to $-7.85 in the current quarter. This performance was $-10.50 […]
ClearPoint Neuro Inc (NASDAQ: CLPT) stock closed at $7.17 on 3/13/24 after a major increase of 18.5%. Moreover, trading volume in this advance was exceptionally high at 441% of normal. The stock has been strong […]
Over the next 6 years, A-Mark Precious Metals shares will need to reach $51 to achieve average annual stock market performance of 9.0%. To achieve Upper quartile performance, A-Mark Precious Metals’ stock price will need […]
On 3/12/24, Sunrun Inc (NASDAQ: RUN) stock suffered a major decline of -10.9%, closing at $10.70. This decline was accompanied by normal trading volume. The stock has been weak relative to the market over the […]
Identiv Inc (NASDAQ: INVE) stock closed at $7.12 on 3/12/24 after a major decline of -17.5%. Moreover, trading volume in this decline was exceptionally high at 439% of normal. The stock has declined -18.2% during […]
Extremely significant negative changes in Editas Medicine Inc (NASDAQ: EDIT) investment behavior have recently occurred: its longer term price trend turned down, and its shorter term price trend turned down. Recent meaningful negative changes in […]
BUSINESS Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research